During the past decade, Nune Eye Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nune Eye Hospital" are "Central Serous Chorioretinopathy" (1 trials), "Conjunctivitis, Allergic" (1 trials), "Diabetic Macular Edema" (1 trials), "Neovascular Age-related Macular Degeneration" (1 trials) and "Wet Macular Degeneration" (1 trials). Many other conditions were trialed in "Nune Eye Hospital" in a lesser frequency.

Most popular intervention types in "Nune Eye Hospital" are "Drug" (4 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (2 trials), "Sham Procedure" (2 trials), "Aflibercept" (1 trials), "Alcaftadine Ophthalmic Solution 0.25%" (1 trials) and "Ozurdex intravitreal injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nune Eye Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Nune Eye Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Nune Eye Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nune Eye Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".